Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > A secret pharmaceutical partner

<< Previous

Bullboard Posts

Next >>

Post by Solid1on Apr 06, 2024 4:21am

182 Views

Post# 35974495

A secret pharmaceutical partner

As far as the generic of Epidiolex is concerned, I think it's more about the active ingredients in this drug... The GW/Jazz patents relate to the treatment of epilepsy.

If the pharma partner has a completely new treatment method in mind, there should be no major litigation as CBD is not patentable. From this perspective, any newly approved CBD-based drug is a generic of Epidiolex

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"